Stephen Worsley
Corporate Officer/Principal at LYTIX BIOPHARMA
Profile
Stephen Worsley currently works at Lytix Biopharma AS, as Chief Business Officer from 2022.
Mr. Worsley also formerly worked at Tripos, Inc., as Director-Business Development, Abgenix, Inc., as Director-Business Development, OHM Technologies, as Director-Business Development, Avid Bioservices, Inc., as Vice President-Business Development from 2013 to 2017, Raven Biotechnologies, Inc., as Vice President-Business Development, Precigen, Inc., as Vice President-Business Development, ZP Opco, Inc., as Vice President-Business Development from 2008 to 2010, Sutro Biopharma, Inc., as Chief Business Officer from 2018 to 2020, Centrose LLC, as Chief Business Officer, Redwood Bioscience, Inc., as Vice President-Strategic Business Development, and Indi Molecular, Inc., as Sr. Vice President-Business Development from 2017 to 2018.
Mr. Worsley received his Masters Business Admin degree from the University of Washington and undergraduate degree from the University of Utah.
Stephen Worsley active positions
| Companies | Position | Start |
|---|---|---|
| LYTIX BIOPHARMA | Corporate Officer/Principal | 05/09/2022 |
Former positions of Stephen Worsley
| Companies | Position | End |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 31/12/2019 |
Indi Molecular, Inc.
 Indi Molecular, Inc. BiotechnologyHealth Technology Indi Molecular, Inc. is a life sciences company that develops a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. It offers products used by physicians and patients to manage complex and serious diseases like cancer, diabetes, and Alzheimer's. The company was founded by Michael Phelps, Albert A. Luderer, Leroy E. Hood, and Jim Heath in 2013 and is headquartered in Culver City, CA. | Corporate Officer/Principal | 31/07/2018 |
| AVID BIOSERVICES, INC. | Corporate Officer/Principal | 30/09/2017 |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 31/12/2009 |
Redwood Bioscience, Inc.
 Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Training of Stephen Worsley
| University of Washington | Masters Business Admin |
| University of Utah | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AVID BIOSERVICES, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Private companies | 8 |
|---|---|
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Commercial Services |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Tripos, Inc.
 Tripos, Inc. Packaged SoftwareTechnology Services Tripos, Inc. engages in the provision of drug discovery informatics products and services. The company was founded by Garland Marshall in 1979 and is headquartered in St. Louis, MO. | Technology Services |
ZP Opco, Inc.
ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Health Technology |
Centrose LLC
 Centrose LLC Pharmaceuticals: MajorHealth Technology Centrose LLC discovers and develops therapeutics. It focuses on the chemistry and biology unique to the creation of EDC technology. The company was founded by James R. Prudent in 2007 and is headquartered in Middleton, WI. | Health Technology |
| OHM Technologies | |
Indi Molecular, Inc.
Indi Molecular, Inc. BiotechnologyHealth Technology Indi Molecular, Inc. is a life sciences company that develops a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. It offers products used by physicians and patients to manage complex and serious diseases like cancer, diabetes, and Alzheimer's. The company was founded by Michael Phelps, Albert A. Luderer, Leroy E. Hood, and Jim Heath in 2013 and is headquartered in Culver City, CA. | Health Technology |
Redwood Bioscience, Inc.
Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- Stephen Worsley
